PRCT
|
PROCEPT BioRobotics Corporation
|
0.01%
|
US
|
NASDAQ
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
PETQ
|
PetIQ, Inc.
|
0.01%
|
US
|
NASDAQ
|
OSUR
|
OraSure Technologies, Inc.
|
0.01%
|
US
|
NASDAQ
|
OPRX
|
OptimizeRx Corporation
|
0.01%
|
US
|
NASDAQ
|
OFIX
|
Orthofix International N.V.
|
0.01%
|
US
|
NASDAQ
|
OCGN
|
Ocugen, Inc.
|
0.01%
|
US
|
NASDAQ
|
NVTA
|
Invitae Corporation
|
0.01%
|
US
|
NYSE
|
NUVL
|
Nuvalent, Inc.
|
0.01%
|
US
|
NASDAQ
|
NSTG
|
NanoString Technologies, Inc.
|
0.01%
|
US
|
NASDAQ
|
NRIX
|
Nurix Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
NKTR
|
Nektar Therapeutics
|
0.01%
|
US
|
NASDAQ
|
MRUS
|
Merus N.V.
|
0.01%
|
US
|
NASDAQ
|
MORF
|
Morphic Holding, Inc.
|
0.01%
|
US
|
NASDAQ
|
MLAB
|
Mesa Laboratories, Inc.
|
0.01%
|
US
|
NASDAQ
|
MGNX
|
MacroGenics, Inc.
|
0.01%
|
US
|
NASDAQ
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
MCRB
|
Seres Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
KURA
|
Kura Oncology, Inc.
|
0.01%
|
US
|
NASDAQ
|
KROS
|
Keros Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|